EICHOR
● Not Yet Recruiting
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Condition: Schizophrenia · Sponsor: Leal Therapeutics, Inc
About this study
The purpose of this clinical trial is to learn whether the investigational drug LTX-001 is safe and well tolerated in adults with a diagnosis of schizophrenia who are having a recent worsening of their symptoms (an acute exacerbation). Additional questions it aims to answer are: * how does the amount of the study drug in the body change over time (pharmacokinetics) * how does the study drug affect the symptoms of schizophrenia * how do certain markers in the blood change after administration of LTX-001 (pharmacodynamics) Researchers will compare different dose levels of LTX-001 to an inactive product (placebo) to see what differences there are between the two treatments. After successfully screening for the study, participants will stay in a research unit for about five weeks and return one week later for a follow-up visit.
This description comes directly from the study's public registry record.
Talk to the study team
Clinical Trials Information Medical Monitor · 267-503-4800 · clinical.trials@lealtx.com
Study Director Medical Monitor
Always discuss trial participation with your own doctor first.
Locations (10)
| Pillar Clinical Research, LLC | Little Rock, Arkansas, United States | — |
| Collaborative Neuroscience Research, LLC | Los Alamitos, California, United States | — |
| University Clinical Research-DeLand, LLC d/b/a Accel Research Sites - DeLand Clinical Research Unit | DeLand, Florida, United States | — |
| Behavioral Clinical Research, Inc. | Hollywood, Florida, United States | — |
| CenExel Hollywood FL | Hollywood, Florida, United States | — |
| Innovative Clinical Research, Inc. | Miami Lakes, Florida, United States | — |
| CenExel iResearch, LLC | Decatur, Georgia, United States | — |
| CBH Health LLC., dba CenExel Gaithersburg MD | Gaithersburg, Maryland, United States | — |
| Hassman Research Institute, LLC | Marlton, New Jersey, United States | — |
| Pillar Clinical Research, LLC | Richardson, Texas, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07734493